CNBC

Novo Nordisk shares slide after guidance disappoints investors

Novo Nordisk raised its financial outlook as it tries to catch up with rival Eli Lilly in the booming GLP-1 market.

This is a short WorldPing brief. The full report was published by CNBC.

Read the full report at CNBC

Related news